| Nona‐valent vaccine (Luxembourg 2015) | |
| Manufacturer | Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA) |
| Antigens | L1 VLPs of HPV6 (30 μg), HPV11 (40 μg), HPV16 (60 μg), HPV18 (40 mg), HPV31 (20 μg), HPV33 (20 μg), HPV45 (20 μg), HPV52 (20 μg) and HPV58 (20 μg). |
| Vaccination schedule | 3 doses: at day 1, month 2 and month 6 |
| Adjuvant | 500 μg amorphous aluminium hydroxyl‐phosphate sulphate |
| Trade name | Gardasil‐9 |
|
Produced by recombinant technology using |
Saccharomyces cerevisae (baker’s yeast) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.